Skip to main content

Table 4 Prognostic factors affecting LC and OS rates on univariate analysis

From: Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach

Factors

Lesion (n°)

LC (rates)

pvalue

Patients (n°)

OS (rates)

pvalue

1 years

2 years

3 years

1 years

2 years

3 years

Site of irradiated metastases

 

    Lung

60

85%

75%

70%

0.095

40

87%

68%

58%

0.34

    Liver

52

95%

90%

81%

42

78%

61%

44%

Cumulative GTV

 

    < 3 cm

-

-

-

-

-

47

90%

70%

61%

0.02

    > 3 cm

     

35

73%

56%

26%

SBRT dose

 

    ≥ 60 Gy

58

97%

92%

83%

0.043

46

80%

57%

38%

0.69

    < 60 Gy

52

85%

70%

70%

36

86%

54%

-